Inexpensive Biotech Stock Has Healthy Pipeline Of New Drugs Forbes The biotech space is likely to find greater focus in the wake Amgen Amgen's agreement to purchase of ONXY Pharmaceuticals (ONXX). Investors looking for strong growth at a reasonable price in the biotech sector may want to buy into the Biogen Idec ... |
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment